May. 5 at 5:24 PM
$ONCY ASCO 2026 - KRAS mutated cancers - The KRAS Journey
Saturday, May 30, 2026
1:15 PM-2:30 PM Education Session
ASCO/AACR Joint Session: The KRAS Journey—
Perseverance Pays Off
Location: S100bc
Eric J. Small, MD, FASCO—Chair
University of California San FranciscoWelcome and Introductory Remarks From ASCO President
Lillian L. Siu, MD, FRCPC, FASCO—Chair
Princess Margaret Cancer Centre, University Health Network,
University of Toronto, Princess Margaret Cancer Consortium,
Marathon of Hope Cancer Centres Network
Welcome and Introductory Remarks From AACR President
Stephen Fesik, PhD
Vanderbilt
From Undruggable to Breakthrough: Lessons From the Longest
Road in Targeted Therapy
Melissa Lynne Johnson, MD, FASCO
Sarah Cannon Research Institute
KRAS-Directed Therapy: A Clinical Update
✔️ Eileen M. O’Reilly, MD, FASCO
Memorial Sloan Kettering Cancer Center
Beyond KRAS G12C: Novel Approaches and Future Directions
https://oncolyticsbiotech.com/about-us/
